These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15164324)

  • 21. Statins reduce oxidized low-density lipoprotein levels, but do not alter soluble intercellular cell-adhesion molecule-1 and vascular cell-adhesion molecule-1 levels in subjects with hypercholesterolaemia.
    Rosenson RS; Wolff D; Tangney CC
    Clin Sci (Lond); 2004 Feb; 106(2):215-7. PubMed ID: 12967321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin C prevents metal ion-dependent initiation and propagation of lipid peroxidation in human low-density lipoprotein.
    Retsky KL; Frei B
    Biochim Biophys Acta; 1995 Aug; 1257(3):279-87. PubMed ID: 7647104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B.
    Chait A; Brazg RL; Tribble DL; Krauss RM
    Am J Med; 1993 Apr; 94(4):350-6. PubMed ID: 8475928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study.
    Hoogeveen RC; Ballantyne CM; Bang H; Heiss G; Duncan BB; Folsom AR; Pankow JS
    Diabetologia; 2007 Jan; 50(1):36-42. PubMed ID: 17136392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic.
    Fuhrman B; Volkova N; Rosenblat M; Aviram M
    Antioxid Redox Signal; 2000; 2(3):491-506. PubMed ID: 11229363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro.
    O'Brien RC; Luo M
    Metabolism; 1997 Dec; 46(12 Suppl 1):22-5. PubMed ID: 9439554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of the hormonal changes during the normal menstrual cycle in healthy young women on soluble adhesion molecules, plasma homocysteine, free radical markers and lipoprotein fractions.
    Elhadd TA; Neary R; Abdu TA; Kennedy G; Hill A; McLaren M; Akber M; Belch JJ; Clayton RN
    Int Angiol; 2003 Sep; 22(3):222-8. PubMed ID: 14612848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced susceptibility of low-density lipoprotein to in vitro oxidation in type 1 and type 2 diabetic patients.
    Beaudeux JL; Guillausseau PJ; Peynet J; Flourie F; Assayag M; Tielmans D; Warnet A; Rousselet F
    Clin Chim Acta; 1995 Aug; 239(2):131-41. PubMed ID: 8542651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma thiols inhibit hemin-dependent oxidation of human low-density lipoprotein.
    Lynch SM; Campione AL; Moore MK
    Biochim Biophys Acta; 2000 May; 1485(1):11-22. PubMed ID: 10802245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble cell adhesion molecules and parameters of lipoprotein metabolism in patients with severe burns.
    Rassoul F; Richter V; Kistner C; Wisser D; Reichert B
    West Indian Med J; 2009 Nov; 58(5):417-21. PubMed ID: 20441058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between plasma glucose and insulin responses to oral glucose, LDL oxidation, and soluble intercellular adhesion molecule-1 in healthy volunteers.
    Chen NG; Azhar S; Abbasi F; Carantoni M; Reaven GM
    Atherosclerosis; 2000 Sep; 152(1):203-8. PubMed ID: 10996356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria.
    Lim SC; Caballero AE; Smakowski P; LoGerfo FW; Horton ES; Veves A
    Diabetes Care; 1999 Nov; 22(11):1865-70. PubMed ID: 10546021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced antioxidant potential & sensitivity to oxidation in plasma low density lipoprotein fraction in type 2 diabetes mellitus patients.
    Ergüder IB; Karagenç N; Karaca L
    Indian J Med Res; 2006 Aug; 124(2):207-10. PubMed ID: 17015936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations.
    Miles EA; Thies F; Wallace FA; Powell JR; Hurst TL; Newsholme EA; Calder PC
    Clin Sci (Lond); 2001 Jan; 100(1):91-100. PubMed ID: 11115423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of high-density lipoprotein cholesterol effects on the endothelial function in hyperlipemia.
    Lupattelli G; Marchesi S; Lombardini R; Siepi D; Bagaglia F; Pirro M; Ciuffetti G; Schillaci G; Mannarino E
    Metabolism; 2003 Sep; 52(9):1191-5. PubMed ID: 14506626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The susceptibility of low-density lipoprotein to in vitro oxidation is increased in hypercholesterolemic patients.
    Cominacini L; Pastorino AM; Garbin U; Campagnola M; de Santis A; Davoli A; Faccini G; Bertozzo L; Pasini F; Pasini AF
    Nutrition; 1994; 10(6):527-31. PubMed ID: 7703599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceruloplasmin as low-density lipoprotein oxidase: activation by ascorbate and dehydroascorbate.
    Feichtenhofer S; Fabjan JS; Abuja PM
    FEBS Lett; 2001 Jul; 501(1):42-6. PubMed ID: 11457453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia.
    Stefanutti C; Di Giacomo S; Vivenzio A; Isacchi GC; Masella R; Caprari P; Varì R; Tarzia A; Mosiello A; Cantafora A
    Clin Sci (Lond); 2001 Feb; 100(2):191-8. PubMed ID: 11171288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compositional lipoprotein changes and low-density lipoprotein susceptibility to oxidation in chronic renal failure patients with heavy proteinuria.
    Karabina SA; Pappas H; Miltiadous G; Bairaktari E; Christides D; Tselepis A; Elisaf M; Siamopoulos K
    Nephron Clin Pract; 2003; 95(3):c77-83. PubMed ID: 14646367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidation resistance of LDL in hypertriglyceridaemic patients treated with ciprofibrate.
    Nagyová A; Raslová K; Ginter E
    Physiol Res; 1998; 47(3):185-90. PubMed ID: 9803483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.